While Diasonics set up a separate company to sell Vingmed ultrasoundscanners in the U.S. cardiology market, Siemens moved in the oppositedirection last month. The German vendor initiated consolidationof the sales and service staff of its
While Diasonics set up a separate company to sell Vingmed ultrasoundscanners in the U.S. cardiology market, Siemens moved in the oppositedirection last month. The German vendor initiated consolidationof the sales and service staff of its cardiology-focused ultrasounddivision in San Ramon, CA, with the radiology and vascular groupat Quantum Medical Systems in Issaquah, WA.
Both ultrasound offices will be retained in the consolidationprocess, and the two brand names will continue for the time being,said Lonnie Edelheit, Quantum president.
Siemens' acquisition of Quantum a year ago (SCAN 4/11/90) provideda foothold in the high-end radiology ultrasound market. Siemensbases its worldwide ultrasound business unit in the U.S.
Like most other multimodality medical imaging companies, Siemenshas had to play catch-up with smaller, dedicated ultrasound firmsthat have been successful in the technology-intensive radiologyultrasound field.
Siemens decided to combine the two sales and service groupsto provide a unified focus for its ultrasound business and improveresponsiveness to customers, Edelheit told SCAN. The unified salesand service group will handle scanners in the cardiac, radiology,vascular and ob/gyn private-office markets.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.